The focus of this international meeting is to correlate advances in the morphologic evaluation and integration of findings in the digestive tract and pancreas with functional, cellular and molecular knowledge in a series of plenary and poster sessions. The meeting will provide a venue for interactive discussion of the current state of knowledge in both conventional and specialized nonclinical safety studies of the digestive tract and pancreas. Core sessions will include Normal Digestive Tract Functional Anatomy and Physiology, Inflammatory Bowel Disease, Digestive Tract Toxicity and Risk Assessment, Digestive Tract Carcinogenesis, Biomarkers of Digestive Tract and Pancreatic Injury and Disease, and Pancreatic Toxicity and Carcinogenesis. The symposium keynote address will focus on the gut microbiome and its critical interactions with the digestive tract epithelium and the mucosal immune system during health and disease.
Individual presentations will focus on a mix of traditional and contemporary strategies for the pathophysiologic and toxicologic evaluation of the digestive tract and pancreas. The meeting will also provide a unique forum for reviewing recent progress in developing and optimizing best practices for routine and specialized toxicologic pathology evaluation of digestive tract and pancreas across academia and the pharmaceutical and chemical industries. The symposium will also feature practical case study presentations as part of two scientific sessions: the session on Digestive Tract Toxicity and Risk Assessment and the session on Pancreatic Toxicity and Carcinogenesis.
The digestive tract and pancreas are rapidly growing areas of toxicologic inquiry and regulatory concern, and this symposium promises to be a great opportunity to review and expand your knowledge in this important field.